Stock Alert: Cue (CUE) Climbing 7.86% in Pre-Market Trading for August 5

Equities Staff  |

Cue Biopharma Inc (NASDAQ:CUE) has already gained $0.239 in early trading Friday.

After closing the previous trading session at $3.04, Cue has moved 7.86% higher ahead of market open.

The company is up 16.03% over the last 5 days.

Today could shape up to be an interesting day for Cue investors.

For technical charts, analysis, and more on Cue Biopharma Inc visit the company profile.

Pre-market prices and movements as of 08:10:15 est.

About Cue Biopharma Inc

Cue Biopharma, a clinical-stage biopharmaceutical company, is engineering a novel class of injectable biologics to selectively engage and modulate targeted T cells directly within the patient's body to transform the treatment of cancer, infectious diseases and autoimmune diseases. The company's proprietary platform, Immuno-STAT ™(Selective Targeting and Alteration of T cells) is designed to harness the body's intrinsic immune system without the need for ex vivo manipulation.

To get more information on Cue Biopharma Inc and to follow the company's latest updates, you can visit the company's profile page here: Cue Biopharma Inc's Profile. For more news on the financial markets be sure to visit Equities News. Also, don't forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Symbol info widget is provided by TradingView based on 15-minute-delayed prices. All other article data is provided by IEX Cloud on 15-minute delayed prices or EOD company info.

Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Trending Articles

The Strong Dollar Is a Problem for Stocks
3 Ways Finance Teams Can Navigate Inflation Through Automation



Market Movers

Sponsored Financial Content